On January 28, 2022, the Damon Runyon Cancer Research Foundation announced its newest cohort of Damon Runyon Fellows, 13 outstanding postdoctoral scientists conducting basic and translational cancer research in the laboratories of leading senior investigators. This prestigious, four-year Fellowship encourages the nation's most promising young scientists to pursue careers in cancer research by providing them with independent funding ($231,000 total to each) to work on innovative projects. The Committee also selected six new recipients of the Damon Runyon-Dale F. Frey Award for Breakthrough Scientists. This award recognizes Damon Runyon Fellows who have exceeded the Foundation’s highest expectations and are most likely to make paradigm-shifting breakthroughs that transform the way we prevent, diagnose, and treat cancer. To catapult their research careers—and their impact—Damon Runyon makes an additional investment of $100,000 in these exceptional individuals. “Being awarded the Dale F. Frey Breakthrough Scientist Award will allow me to take risks that I otherwise wouldn’t have,” says Allison Didychuk (photo), PhD. “That includes expanding into new approaches for me, like single molecule biophysics and functional genomics—and purchasing essential equipment that has been held up by supply chain shortages!”